HomeNewsBusinessInterview| Let's forget the history and move on, says IRCTC's CMD Rajni Hasija

Interview| Let's forget the history and move on, says IRCTC's CMD Rajni Hasija

In an interview with Moneycontrol, Hasija said that the company’s management has full powers to decide the rate at which the convenience fee can be charged for bookings tickets on its online platforms and that it’s now time to forget the past.

November 03, 2021 / 20:05 IST
Story continues below Advertisement

Just a week after her company’s stock recovered from the fallout of certain decisions, Rajni Hasija, chairman and managing director of Indian Railway Catering and Tourism Corp Ltd (IRCTC) is now looking to focus on the positive trend of the recovering Indian economy and is hopeful that IRCTC’s strong performance in July-September is replicated for the rest of the year.

Last week shares of IRCTC fell 27 percent intraday on September 29 after the company informed exchanges that the railway ministry had asked it to share half of all the convenience fee revenue it earned. They recovered later in the day after the decision was withdrawn.

Story continues below Advertisement

In an interview with Moneycontrol, Hasija said that the company’s management has full powers to decide the rate at which the convenience fee can be charged for bookings tickets on its online platforms and that it’s now time to forget the past.

She added that IRCTC is expecting its trend of strong bookings to continue in the first half of November and December and is hopeful that a third wave of COVID-19 does not play spoilsport.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show